Adma Biologics reported $137.67M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Adma Biologics USD 137.67M 27.94M Sep/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Novavax USD 94.96M 62.81M Sep/2024
Omeros USD 8.08M 440K Jun/2024
Takeda JPY 757.92B 55.68B Dec/2025